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Abstract
In response to the growing need for functional analysis of the human genome, we have developed a platform for high-
throughput functional screening of genes overexpressed from lentiviral vectors. Protein-coding human open reading
frames (ORFs) from the Mammalian Gene Collection were transferred into lentiviral expression vector using the highly
efficient Gateway recombination cloning. Target ORFs were inserted into the vector downstream of a constitutive promoter
and upstream of an IRES controlled GFP reporter, so that their transfection, transduction and expression could be monitored
by fluorescence. The expression plasmids and viral packaging plasmids were combined and transfected into 293T cells to
produce virus, which was then used to transduce the screening cell line. We have optimised the transfection and
transduction procedures so that they can be performed using robotic liquid handling systems in arrayed 96-well microplate,
one-gene-per-well format, without the need to concentrate the viral supernatant. Since lentiviruses can infect both dividing
and non-dividing cells, this system can be used to overexpress human ORFs in a broad spectrum of experimental contexts.
We tested the platform in a 1990 gene pilot screen for genes that can increase proliferation of the non-tumorigenic
mammary epithelial cell line MCF-10A after removal of growth factors. Transduced cells were labelled with the nucleoside
analogue 5-ethynyl-29-deoxyuridine (EdU) to detect cells progressing through S phase. Hits were identified using high-
content imaging and statistical analysis and confirmed with vectors using two different promoters (CMV and EF1a). The
screen demonstrates the reliability, versatility and utility of our screening platform, and identifies novel cell cycle/
proliferative activities for a number of genes.
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Introduction
Elucidating gene function is a pressing challenge for human
biology and medicine. Given that the human genome consists of
up to 25000 protein-coding genes [1], this task requires high-
throughput approaches. An additional requirement of such
approaches is flexibility of the research platform, since each gene
can participate in multiple functional networks depending on
biological and environmental conditions.
Although gene function can be inferred from sequence
homology to characterised genes as well as expression patterns,
the most definitive answers come from observing how altering
expression of a gene affects phenotype. Reducing or completely
abolishing gene expression by gene silencing can identify genes
that are necessary for a particular cellular function, while induced
overexpression points to genes that are sufficient to generate a
phenotype. In addition, overexpression allows for analysis of
subcellular protein localisation as well as in-vivo protein-protein
interactions. High-throughput technology for gene silencing
through siRNA, and to a lesser extent shRNA, has been developed
and is now extensively used to screen the human genome [2,3]. In
contrast, so far only a few studies have investigated the effect of
ectopic cDNA expression on a genomic scale using individually
arrayed expression clones. This is in part due to the fact that gene
silencing can be achieved with readily synthetised oligonucleotides
while overexpression requires cloning full length open reading
frames (ORFs) into expression plasmids [4,5]. Another difficulty is
that foreign plasmids can be easily transfected into only a limited
number of human cell types, so that the existing reports have
focused on highly transfectable cell lines such as HEK293T
[6,7,8], U2OS2 [9], HCT116 [10] and SMC1772 [11]. Here we
describe a high-throughput platform for overexpression screening
of the human genome in an arrayed one gene per well format that
circumvents these difficulties by using Gateway cloning and
lentiviral expression vectors.
Lentiviral vectors deliver genes into chromosomes of both
dividing and non-dividing cells, allowing stable expression of
transgenes even in cell lines refractory to transfection [12]. The
range of screenable cell types is further increased by using viral
packaging vectors with pan-tropic envelope proteins such as VSV-
G, which allows transduction of most mammalian cell types. Once
the viral supernatant is generated, it can be used on multiple cell
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lines simultaneously, adding another level of flexibility to viral
vector-based screening platforms.
A number of collections of human ORFs derived by PCR from
the Mammalian Gene Collection have become available in
Gateway-compatible entry vectors [13,14,15], allowing for shuffling
of the ORFs between vectors with efficiency and scalability greatly
exceeding that of traditional cloning methods [4,16,17]. We have
employed a robotic liquid handling system to optimise Gateway
cloning in 96-well microplate format and used it to transfer human
ORFs from the hORFeome collection [15] into a lentiviral
expression plasmid. Using the same microplate format, we have
devised a protocol for robotic transfection of the HEK293Tcell line
which was used to generate an arrayed library of viral supernatants
ready for screening. To test the platform, we performed a pilot
screen using a high-content imaging assay for cell-proliferation.
Cell proliferation control is an essential requirement for all
multicellular organisms and is dependent on complex, highly
organized gene interaction networks. Although cell-cycle regula-
tion has been extensively studied and is well understood in a
number of species, many key components remain elusive. This is
particularly evident in cancer, where the diseased state is
generated in part by the cells escaping normal proliferation
control [18,19]. As the number of genetic perturbations observed
in cancer grows into thousands, it becomes increasingly difficult to
determine which of these changes are driving the disease process
and would therefore make suitable targets for anti-cancer therapy
[20]. Putative candidates could be identified in a genetic
overexpression screen for genes that can drive abnormal cell
proliferation. Since changes in cell proliferation rate can be caused
by variety of external stimuli, methodologies developed for this
screen are applicable to analysis of other cellular functions such as
response to pathogens, toxins, nutrients or drugs.
Here we describe a screen for genes that could induce cells to
proliferate in the absence of necessary growth factors. We used
arrayed viral supernatants to overexpress 1990 genes in the non-
tumorigenic human mammary epithelial cell line MCF-10A, and
looked for genes that promote cell proliferation after removal of
the epidermal growth factor (EGF), which is required for
continued growth in this cell line. In order to keep the platform
scalable to whole genome investigation, we used a previously
described end-point DNA synthesis assay as a marker for
proliferation [21]. The assay relies on quantifying nucleotide
analogue EdU incorporation in transduced and untransduced cells
in each well, using a high-content imager. Putative hits were
subsequently confirmed in time course experiments involving two
different expression vectors.
Results
Library construction
For this pilot study we picked 1320 genes for which published
expression profiles or functional screening data suggested
involvement in cell cycle regulation [22,23,24,25], myeloid cell
proliferation [26] and/or protein phosphorylation [27,28], as well
as 670 randomly selected clones (Table S1). Predicted insert size
ranged from 84 to 7116 bp, ensuring that developed protocols
were not biased for particular ORF length.
A diagram of the library construction pipeline is shown in
Figure 1. All experiments were performed in 96-well microplate
format. The first step in generating the human ORFeome lentiviral
expression library was transfer of ORFs from the entry vectors into
plv101G destination vector using the Gateway LR recombinase
reaction. During this step, the human ORF replaces the ccdB gene
downstream of a constitutive promoter - CMV for the initial
screening, and CMV or EF1a for the hit-validation experiments.
The ORF is inserted upstream of the IRES-controlled hrGFP, so
that transgene expression can be monitored by GFP fluorescence.
We found that the recombinase reaction on the robotic platform
could be performed efficiently in a volume of 5 ml/well, with as little
as 1 ng of entry clone DNA. Under these conditions, of 600 clones
sampled, only 3% either failed to produce plasmid DNA (12 clones)
after transformation, or produced incorrectly-sized products (6
clones) in restriction digest analysis.
In the next step, expression plasmids were combined with viral
packaging plasmids and transfected into HEK293T cell line to
produce virus-containing supernatant. During optimisation exper-
iments we measured whole-well GFP fluorescence using a plate
reader to assess levels of packaging cell transfection. This
measurement was found to correlate well with the proportion of
GFP positive cells measured by flow cytometry and the high
content imager (Figure S1). Whole-well GFP fluorescence of virus-
producing cells also served as an estimate of the relative amount of
virus produced, as it would have been impractical to calculate
titres and multiplicity of infection (MOI) values for thousands of
samples prior to screening. In general, observed GFP fluorescence
of virus-producing cells and titres obtained from the derived viral
supernatant varied on average by less than 15% between replicates
of the same clone, but values obtained from different transgenes
varied by up to a hundred fold (Figure S2). The greatest source of
variation in viral titres was the overexpressed ORF. In the primary
screen presented here the percentage of GFP positive cells between
ORFs ranged from 0 to 79% (Table S1). It is possible that clones
that produced low titres code for proteins detrimental to either the
virus-producing HEK293T cells or the test MCF-10A cell line.
Nevertheless, the titres achieved allowed us to sample enough
transduced cells for statistical analysis of 95% of the clones in at
least one round of screening. One virus-producing well produced
sufficient supernatant for infection of 6 wells of assay cells, allowing
for repeat experiments and/or multiple assays from a single virus
production run.
Overexpression screen
The virus generated from the 1990 expression clones was used
to assess the ability of the overexpressed ORFs to induce increased
proliferation in the MCF-10A cells after EGF removal. In
preliminary experiments in the 96-well microplate format we
determined the optimal assay conditions that significantly reduced
cell proliferation but did not significantly reduce cell viability after
exposure to the virus. Under these conditions cells not exposed to
virus undergo 2–3 division cycles after EGF withdrawal before
depleting the media and arresting in the G1 phase of the cell cycle.
As summarized in Figure 2, cells were plated at 2000 cells per well
in complete media (containing EGF and 5% v/v horse serum) on
Day 0, and transduced on Day 1. Medium without EGF and
containing 1% v/v serum was used for subsequent volume top-up
and a Day 2 medium change. On Day 4, cells were pulsed for 2 h
with the nucleotide analogue EdU which is incorporated into the
nuclear DNA of cells in S phase. Cells were then fixed and
processed for high-content imaging by staining with DAPI to
define nuclei and measure DNA content, and by cross-linking
EdU with the fluorescent label Cy5 to mark S phase nuclei. Plates
were then scanned on a high-content imager, and individual nuclei
scored for DAPI, GFP and Cy5 fluorescence, based on cumulative
total (DAPI, Cy5) or average (GFP) nuclear pixel intensity.
Analysis of screening data and hit selection
Image analysis data were further processed using software
scripts written in the R programming language (http://cran.r-
Platform for Lentiviral Overexpression Screening
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project.org/), as summarized in Figure 3.The first step in the
analysis was to determine the GFP and EdU status (positive or
negative) of each cell based on observed fluorescence intensity. To
compensate for the artefacts due to uneven background staining
and well crowding, this was done using robust regression methods,
as detailed in Materials and Methods, and Figure S3.
The second step was to test whether EdU incorporation rates in
the transduced (GFP positive) cells were higher than in the
Figure 1. Lentiviral expression library generation. Step 1 shows the structures of the plasmids involved in the Gateway LR recombination
reaction between the ORFeome entry vector and the lentiviral expression vector. attL1, attL2, attR1, attR2 are the recombination sites,: ORF - open
reading frame; LTR - long terminal repeats (‘‘S’’ in the 39 LTR indicates that it harbours a deletion rendering it self-inactivating); CMV/EF1a – promoter;
IRES – internal ribosome entry site sequence; GFP – green fluorescent protein, ccdB – gene encoding a bacterial toxin (which is replaced by the ORF
and is used to select against non-recombinant plasmids). Steps 2, 3 and 4 are viral packaging in 293T cells, collection of lentivirus-containing
supernatant and transduction of target cells, respectively. For details see Materials and Methods.
doi:10.1371/journal.pone.0020057.g001
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Figure 2. Workflow for the screening of the MCF-10A cells. The left-hand panel shows plate manipulations and cell treatments for each day of
the screen. The right-hand panel shows a representative image of a scanned field as a pseudo-colour overlay (top) of individual scanning channels
(bottom) shown individually for the boxed area (DAPI – blue, GFP – green, EdU – red, scale bar = 50 mM). Blue lines in the enlargements encircle the
object (nucleus) area selected by the scanning algorithm. See Materials and Methods for further details.
doi:10.1371/journal.pone.0020057.g002
Figure 3. Data analysis steps used to identify hits. Image analysis data was exported from the Cellomics ArrayScan instrument and further
analysed using the R programming platform. The first step in analysis is assignment of Edu and GFP status to each cell, (See also Figure 2 and Figure
S3). Following further data processing (see Materials and Methods), hits were selected based on Q-Q plots for z-scores. The expected z-score
distribution (x axis) is plotted against the observed scores (y axis), and a hit threshold (blue solid line) set where observed values are outside the 95%
confidence interval (red dashed line) from the expected y = x diagonal (red solid line). Empty vector negative controls (light blue circles) lie on the
diagonal, while the positive control wells, containing cells overexpressing CCNE1 (red circles), are in the predicted hit region.
doi:10.1371/journal.pone.0020057.g003
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untransduced (GFP negative) population in the same well using a
z-score based on a binomial distribution. As there was consider-
able variability between plates, z-scores were then normalized by
plate median centering. To obtain z-score thresholds for hit
selection, the observed z-score distribution was compared to the
predicted normal distribution for a similar mean and standard
deviation using Q-Q plots (Figure 3). Thresholds were visually
determined by selecting values that lie above the 95% confidence
interval from the predicted y = x diagonal. Each plate contained at
least 3 wells transduced with empty-vector plv101 which was used
as a negative control. As a positive control we used wells
transduced with cyclin E1 (CCNE1)-expressing lentivirus, as this
gene significantly increased EdU incorporation rates in prelimi-
nary experiments. As expected, the negative control plv101 vector
control scores are distributed along the y = x diagonal, while the
CCNE1 positive control z-scores lie significantly above the line
(Figure 3).
When the data were analysed in this way, five out of 144 vector
control wells were picked as hits (false positive rate = 3.5%), while
one in 15 CCNE1 wells was missed in two rounds of screening
(false negative rate = 6.7%). Since this indicated that our false
negative rate exceeded the false positive rate, and since this was a
proof-of-principle pilot screen, we chose to include in further
analysis 128 clones, 106 of which behaved as hits (based on Q-Q
plots) in at least one round of screening and 40 of those were hits in
both rounds (Table S2). A further 22 non hit clones were selected
to further assess the specificity of the screen and analysis.
Confirmation and characteristics of hits from the primary
screen
Since the ORFeome collection clones were originally derived
from PCR products and thus potentially contained multiple DNA
species, we remade virus from three single colony isolates for each
of the 128 selected genes and passed them through another round
of screening. In this secondary/validation screen, z-scores were
normalized against empty vector controls. The inserts of the high-
scoring clones were sequenced and confirmed to match the
sequence of the corresponding MGC clone indicated in Table S1.
The 47 genes for which at least two of the three colonies were
verified as hits in the EdU assay are listed in Table 1.
These validated hits include 10 (1.5%) of the randomly selected
genes (Functional criterion U, Table 1) and 37 (2.8%) of the genes
preselected for screening based on their putative function (C-cell
cycle, P-phosphoregluation, ML- myeloid cell proliferation, MR-
mitotic regulation). Of the 19 hits that were included based on
demonstrated periodic cell cycle expression pattern, only three
were specifically associated with G1 phase. Comparison to
published functional screens specifically addressing cell cycle and
proliferation in human cells revealed that knockdown of 12 of our
hit genes produced a cell cycle defect in other systems
[24,29,30,31,32] while the overexpression of CDK9, CRK, and
CLK2 also increased proliferation in human hepatoma cell line
SMMC7721 [11]. CDK 9 overexpression also increased prolifer-
ation of human osteosarcoma cell line U20S2 [9], while CRK,
CDK9, DCAF7, NEK6, GNB1, SPOP, and WW2 also increased
proliferation in mouse fibroblasts [11]. In contrast, overexpression
of APEX1, CYTH2, CDK2, DPYSL3 and KRT19 has been
reported to decrease proliferation in other cell lines (Table 1)
[9,11]. However, it should be noted that the CDK2 cDNA used by
Harada et al [9] encoded an extensively truncated protein and thus
may not be comparable.
When we compared the list of hits to the background of
screened genes using the Functional Annotation Clustering tool on
the DAVID Bioinformatic Resources web site [33], no significant
enrichment for any functional cluster was found. This is not
surprising, since our background set was biased towards genes
involved in cell cycle, phosphoregulation and myeloid cell
proliferation. Additional broad functional categories identified by
DAVID tool containing multiple hits included nucleotide and
nucleic acid metabolism (APEX1, CDK2, CDK9, CRK,
DPYSL3, HNRNPH2, HOXB5, IRAK3, NAB2, RPS6KA4,
SETD2, SOD1, SPOP, TK1), cell-surface receptor signalling
(GNA15, GNB1, IRAK, RGS20), cell proliferation (BUB3,
CDK2, CDK9, GNB1, IGSF4, NAB2), membrane organisation
(CYTH2, PACSIN1, SH3GL2, SOD1), actin cytoskeleton
organisation (CRK, CYTH2, KRT19, SPOP), and protein
catabolic process (BUB3, CAPN3, CDC20, IRAK3, SPOP,
UBE2S, WWP2). Two of the hit genes, C2orf83 and CELA2B,
have only been electronically annotated and no functional studies
have so far been reported. CAPN3 was represented by two
independent clones, representing different splice variants, adding
confidence to its hit status.
Proliferative activity of validated hits
From the multiple rounds of screening we identified 47 genes
that satisfy criteria for increased nucleotide incorporation rate,
suggesting that they may be increasing cell proliferation after EGF
removal. We took advantage of the flexibility of our platform to
further analyse the effect of hit ORFs on cell proliferation rate and
cell cycle profile. These hit ORFs were also subcloned into
alternative lentiviral vector plv411G, which is identical to plv101G
except that it utilises the EF1a promoter in place of the CMV
promoter. The EF1a promoter presented advantages over the
CMV promoter when we generated stable cell lines overexpressing
transgenes. In the MCF-10A cell line background we detected
silencing of the CMV promoter, while the EF1a promoter
maintained stable expression through multiple cell passages and
at least one freeze/thaw cycle (data not shown). With these two
sets of expression clones we performed a time course experiment
similar to the assay described in Figure 2, except that triplicate
plates were EdU labelled and harvested on days 2 and 4 (i.e. 1 and
3 days respectively after transduction and EGF withdrawal). This
allowed us to measure the effect of transgene overexpression on
the increase in cell number, as well as to observe the changes in
cell cycle induced by transduction and EGF withdrawal. As a
negative control we used a clone expressing a 24 amino acid
truncated version of CPNE3 which produced neutral z-scores in
screens described here, as well as in previous preliminary
experiments. The results for all 47 genes are presented in Tables
S3 and S4, while the data for the 11 genes that significantly
(P#0.05) increased both cell number and EdU incorporation rate
compared to control (see below) are shown in Figure 4.
In general, the CMV promoter drove stronger GFP expression,
detected as more intense fluorescence which was detectable earlier
compared to EF1a driven expression. On day 2 (26 hr post-
transduction), the median number of GFP positive cells per well
across the 3 test plates was 850 with the CMV promoter compared
to only 220 with the EF1a promoter. At this time 26% of EF1a
driven transgenes produced less than 50 GFP positive cells per
well, making them unsuitable for statistical analysis. In contrast, on
Day 4, wells transduced with EF1a driven transgenes had more
GFP positive cells, with a median of 5214 compared to 2771
median GFP positive cells per well produced by CMV driven
transgenes. This corresponded to 74% and 35% respectively of
total cells counted per well (Figure 4C, Table S3).
Since proliferation rates of transduced cells in this experiment
could not be accurately determined given the changes in GFP
expression, we calculated the increase in total cell numbers in
Platform for Lentiviral Overexpression Screening
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Table 1. Identity and characteristics of confirmed EdU incorporation hits: function criteria, cell-cycle expression pattern and
activity in related functional screens.
Symbol Description Function criteria* Cell cycle phase{
Functional
screens1
APEX1 APEX nuclease (multifunctional DNA repair enzyme) 1 ML 12,22
ATOX1 ATX1 antioxidant protein 1 homolog U 6
BUB3 budding uninhibited by benzimidazoles 3 homolog (yeast) C Ma,G2b 4b
C2orf83 chromosome 2 open reading frame 83 U
CAPN3 calpain 3, (p94) ML
CDC20 cell division cycle 20 homolog C Ma, G2c 4a,4b
CDK2 cyclin-dependent kinase 2 MR, P 12,5
CDK9 cyclin-dependent kinase 9 C, P G2a 1+,2+,3+
CELA2B chymotrypsin-like elastase family, member 2B U
CLDN1 claudin 1 ML
CLK2 CDC-like kinase 2 P 1+
CRK v-crk sarcoma virus CT10 oncogene homolog C M/G1b 1+,2+
CYTH2 cytohesin 2 C G2ab 12
DCAF7 DDB1 and CUL4 associated factor 7 C Ma,G2b 2+,3
DPYSL3 dihydropyrimidinase-like 3 C G2a 22
EXOC8 exocyst complex component 8 C Sa
GAPDH glyceraldehyde-3-phosphate dehydrogenase C G2a
GNA15 guanine nucleotide binding protein (G protein), alpha 15 (Gq class) C Ma 3
GNB1 guanine nucleotide binding protein (G protein), beta polypeptide 1 C Sa,M/G1b 2+,3
H2BFWT H2B histone family, member W, testis-specific U
HNRNPH2 heterogeneous nuclear ribonucleoprotein H2 (H9) U
HOXB5 homeobox B5 U
ILKAP integrin-linked kinase-associated serine/threonine phosphatase 2C P
IRAK3 interleukin-1 receptor-associated kinase 3 U
KRT19 keratin 19 C G2a 12,22
KRT40 keratin 40 U
MAK male germ cell-associated kinase P
NAB2 NGFI-A binding protein 2 (EGR1 binding protein 2) C Sa
NDUFS3 NADH dehydrogenase Fe-S protein 3, 30 kDa P
NEK6 NIMA (never in mitosis gene a)-related kinase 6 P 2+
PACSIN1 protein kinase C and casein kinase substrate in neurons 1 U
PDK2 pyruvate dehydrogenase kinase, isozyme 2 P 4a
PPM1G protein phosphatase, Mg2+/Mn2+ dependent, 1G MR, P 5
PSTPIP2 proline-serine-threonine phosphatase interacting protein 2 ML, 5, 6
RBP1 retinol binding protein 1, cellular U
RGS20 regulator of G-protein signaling 20 C Ma
RIT1 Ras-like without CAAX 1 U
RPS6KA4 ribosomal protein S6 kinase, 90 kDa, polypeptide 4 MR, P 5
SETD2 SET domain containing 2 P
SH3GL2 SH3-domain GRB2-like 2 C Sb
SOD1 superoxide dismutase 1, soluble ML 4a,4b
SPOP speckle-type POZ protein C lateG1a 2+,3,4a
SYT5 synaptotagmin V MR 6, 5
TK1 thymidine kinase 1, soluble MR 5
TMEM55A transmembrane protein 55A C Sa
UBE2S ubiquitin-conjugating enzyme E2S C Ma,M/G1b,G2c
WWP2 WW domain containing E3 ubiquitin protein ligase 2 C Sa 2+,4a
ZWINT ZW10 interactor C Sb 4b
Platform for Lentiviral Overexpression Screening
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transduced wells between days 2 and 4 (Table S3). Eleven genes
induced significantly (P#0.05) larger increases in cell number
compared to the control, regardless of the promoter used
(Figure 4A), indicating that they can stimulate cell proliferation.
Of the others, ATOX1, APEX1, CDK9, H2BF2 induced smaller
increases in cell number compared to the control with the CMV
promoter, while MAK and CADM1 failed to produce at least 50
GFP positive cells by Day 4. All others showed growth rates that
were equal or slightly higher but not statistically significantly
different from those of the control and three other non-hits tested
(Table S3). Cells in untransduced wells, or cells in wells exposed to
the mock supernatant (containing empty viral particles only)
exhibited higher growth rates than in any ORF-expressing wells,
indicating that ectopic protein expression or transduction per se had
an anti-proliferative effect (data not shown). The ratio of EdU
incorporation rates for transduced over untransduced cells was
significantly higher for the hits analysed in this experiment
compared to the control (Figure 4B, Table S3), reconfirming that
the hits behaved as observed in the previous rounds of screening
and making it unlikely that the observed increase in proliferation
was caused by the untransduced cells. This is further supported by
the fact that of the 11 proliferation hits, eight had transduction
rates of 60% or more with the plv411 vector.
We tested the effect of the overexpression of two high
confidence hits, CAPN3 and NEK6 in cell lines that have been
sorted by FACS to generate a pure population of transduced cells.
Cells were sorted 8 days after transduction and seeded in complete
(5% HS, EGF) medium. After 48 h the medium was removed and
replaced with either complete medium or medium with no EGF
and 1% HS. Both CAPN3 and NEK6 overexpression induced a
significant (p,0.05) increase in growth rate compared to control
cells (Figure 5A). The increase was comparable to that conferred
by the CCNE1 positive control, and was observed in both
complete and growth-factor reduced media, indicating that the
pro-proliferative effect of these transgenes is not restricted to
overcoming G1 arrest caused by EGF withdrawal. However, by
four weeks following transduction, this increase could no longer be
detected (data not shown). The overexpressing cell lines remained
more than 98% GFP positive and continued to express the
introduced ORF at above normal levels (Figure 5B) through at
least one freeze-thaw cycle and up to 8 subsequent passages,
indicating that the loss of effect was not due to a reduction in
protein expression.
Cells in our screen were exposed to two antiproliferative
conditions: EGF withdrawal which causes accumulation of cells in
G1 phase of the cell cycle [21] and lentiviral infection which has
been shown to promote G2 phase accumulation [34,35]. To
determine which of these antiproliferative conditions the hit
transgenes were overcoming, we examined cell cycle progression
in transduced cells by DNA content analysis. Using the DAPI
intensity histograms obtained by high-content imaging, nuclei
were assigned cell cycle phases based on their deduced DNA
content (G1 = 2N, G2 = 4N, and S = (2N–4N)), by modelling on
the histograms derived from the reference untransduced wells
(Figure 6A). Three hours after plating, cells that had not been
exposed to viral supernatants and were grown in complete media
had a mean G1/G2 ratio of 1.660.13 (n = 12) (Figure 6A). On day
2 (Figure 2) of the assay, after a medium change to 1% serum
without EGF, cells in untransduced wells started accumulating in
G1 (G1/G2 = 2.1–2.4). In contrast, most wells exposed to viral
supernatant had an increased proportion of cells in G2 phase
compared to cells in untransduced wells (Figure 6A, B; Table S4).
Fewer cells were observed in the transduced wells at this time,
indicating that the G2 accumulation was due to G2 block rather
than faster progression through G1/S. This effect was observed
with both CMV and EF1a promoters, and was detected in both
GFP positive and negative cells in transduced wells, as well as in
cells exposed to mock supernatant (from cells transfected only with
the packaging vectors), suggesting that it may be caused by both
empty viral particles as well as the particles containing the ORF
expressing RNA. Irrespective of the promoter used, the G2 phase
accumulation was less pronounced in cells overexpressing hit genes
CADM1, CDC20, CDK2, CELA2B, CLK2, KRT19, NEK6,
PACSIN, or RIT1 compared to control and other hits (Figure 6,
Table S4). On Day 4 of the assay (Figure 6A, and C),
untransduced cells growing in EGF-free media were arresting in
G1 phase, evident from the reduced proportion of cells in S phase
and an increased proportion in G1. This EGF withdrawal-induced
G1 arrest was more pronounced and happened at lower cell
densities compared to the G1 accumulation observed in
untransduced cells in complete media that almost reached
confluence (Figure 6A). In contrast, cells transduced with the
truncated CPNE3 control still had a significantly higher
proportion of cells in G2 phase compared to those in untransduced
wells, although not as high as on day 2. Cells transduced with hit
genes had G2 proportion values between those of the transduced
control and untransduced wells in EGF withdrawal (Figure 6A, C,
Table S4), indicat ingthat at least in some cases transgene
overexpression compensated for the transduction induced G2
phase arrest observed on Day2. For most hit genes, the proportion
of cells in G1 phase was lower compared to the untransduced
controls subjected to EGF withdrawal (Table S4), indicating that
these genes may also compensate for growth factor removal.
Discussion
We have described the development and successful application
of a platform for gain of function screening of large numbers of
human protein-coding genes. The platform brings together
optimised high-throughput approaches for recombinational clon-
ing, lentiviral production, mammalian cell transduction and high-
content imaging, and thereby expands the scope of functional
genomics questions that can be experimentally addressed.
Here we have presented construction and testing of a lentiviral
expression library of 1990 human ORFs in arrayed single gene per
well format. This library has since been expanded to encompass
17,500 clones, which will be described elsewhere. Several features
*Function criteria used for inclusion in the lentiviral ORF library, based on published microarray expression pattern or functional screening result: C- cell cycle phase-
specific expression; ML-Myeloid cell proliferation [26]; P- phosphoregulation [27,28]; MR- mitotic regulation [24]; U- unspecified i.e. randomly picked clones.
{Cell cycle phase-specific expression determined by microarray analysis in: a, primary human foreskin fibroblasts [22] or HeLa cells b, [25] and c, [23].
1Positive (+), negative (2) or neutral (*) effect on cell proliferation detected in either cDNA overexpression screens in: 1, SMMC7721-human hepatoma cells [11]; 2, NIH
3T3 mouse fibroblasts [11]; 3, U2OS-human osteosarcoma cells [9]; or in RNAi-mediated knock-down screens for effects on mitosis detected in 4a- HeLa [29], 4b- Hela
[32], 5- HT29-human colon carcinoma [24], and 6- U2OS cells [31].
doi:10.1371/journal.pone.0020057.t001
Table 1. Cont
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of these libraries maximise utility and efficacy. First, since lentiviral
vectors pseudotyped with the VSV-G envelope protein have been
successfully used to introduce genes into a broad variety of
mammalian cell types [36,37,38] in applications including arrayed
high-throughput shRNA screens [3,24,39], our library expands
the scope of gain-of-function screening. Second, the optimised
high-throughput Gateway cloning enabled robotics-assisted gen-
eration of expression clones and will facilitate clone transfer to
vectors that may contain different features. For example, the
Gateway-compatible lentiviral vector series described by Campeau
et al [16] allows addition of different promoters, selectable markers
and tracking tags to the overexpression clone. We demonstrated
the utility and feasibility of this feature by recloning hit ORFs into
a vector with an alternative promoter. Third, the lack of non-
coding sequences in our library enhances ORF expression since it
eliminates interference by the gene-specific regulatory sequences
that may be contained in untranslated regions of some cDNA
clones. Fourth, a primary screening vector in which ORF
expression, driven by the CMV promoter, is from the same
transcript as an IRES-driven GFP. In this construct, neither ORF
Figure 4. Summary measurements for hits showing increased total cell proliferation. CMV, EF1a indicate values for ORFs expressed under
control of the CMV and EF1a promoters, respectively. A – ratio of total objects counted on day 4 over day 2 of the assay (Figure 2); B – ratio of the
proportion of EdU positive cells in GFP positive over that in GFP negative objects on day 4; C-percentage of GFP positive objects on day4. All bars
represent a mean of three wells, error bars are standard deviation. Genes represented here were significantly different (p#0.05) in A and B from the
control (in this case vectors encoding a truncated peptide originating from CPNE3, which had no effect on proliferation in primary and validation
screens). Data for all genes tested is in Table S3.
doi:10.1371/journal.pone.0020057.g004
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nor GFP expression is affected by frame shifts that are sometimes
caused by slippage in att recombination sites during generation of
entry clones [40]. Monitoring transgene expression by GFP
fluorescence on the high-content imaging platform, rather than
introducing a selectable marker is advantageous since it allows for
comparison of transduced and non-transduced cells in the same
well. It also avoids potential toxic effects of the selection agent as
well as large variations in the total cell number per well. We have
demonstrated that GFP fluorescence of transduced cells correlates
with significantly increased target protein expression by both
quantitative immunocytochemistry at a cell-based level, as well as
in Western blots of proteins from lysates of cells sorted for GFP
expression. Finally, the use of a high-content imager, which can
rapidly scan and measure thousands of cells per well, allowed us to
obtain meaningful data from wells where viral transduction rates
were less than 1 percent, obviating the need to concentrate the
virus. This feature will be particularly useful in cell lines which are
more difficult to transduce. In our pilot screen less than 5% of the
clones failed to produce sufficient titres for analysis. Similar results
were obtained in an unrelated screen using MCF-7 cells
(unpublished observations). Moreover, use of the test gene set
shown in Figure S2 on HaCaT and MDA-MB-231 cells again
gave a similar range of transduction frequencies (data not shown).
We have identified 47 genes whose overexpression can increase
the rate of nucleotide incorporation into DNA in MCF-10A cells
in the absence of EGF. In addition to genes associated with the cell
cycle, phosphoregulation and myeloid cell proliferation which had
been enriched in the screening set, the hits included genes with
functions in nucleic acid metabolism, signal transduction,
cytoskeletal functions and membrane and protein processing.
This broad range of gene functions that can affect rates of nucleic
acid synthesis, and potentially proliferation rates, is indicative of
the complexity of these cellular processes. Comparison of our
results with two published functional screens targeting mammalian
cell proliferation [9,11] has revealed that some genes may be
universally pro-proliferative (eg. CDK9), while others may have
different (eg DCAF7, SPOP) and even opposing (eg. APEX1,
KRT19) effects depending on the system studied. Similar diversity
has been observed between loss of function screens targeting the
cell cycle in different cell types, where the reported hit overlap was
between 6 and 36% [29,32]. Functional studies of individual genes
indicate that this is not a reflection of poor reproducibility of high-
throughput screening, but a consequence of functional promiscuity
of some genes. Among our hits this is exemplified by NEK6,
RIT1, PACSIN and CAPN3, which may have multiple functions
depending on expression context [41,42,43,44,45,46]. In contrast,
BUB3, ZWINT and UBE2S have highly conserved roles in the
cell cycle across many cell systems studied [47,48,49,50,51].
Cell proliferation rate is a quantitative trait dependent on many
extrinsic as well as intrinsic factors. In the high-throughput
screening context, forced overexpression of any gene might be
expected to affect proliferation rate to some extent, generating a
basal level of variability. This variability is further compounded by
technical factors influencing the well microenvironment, such as
minor differences in volume of liquid transfer or position on the
plate, so that any gene identified as a hit must have sufficient pro-
proliferative power to be detected above this level of background
noise. We compensated for this by analysing the screen using z-
scores where the control value is derived from non-transduced, i.e.
GFP negative, cells in the same well. The caveat of this approach is
that secreted proteins or proteins that can increase proliferation in
neighbouring cells through paracrine pathways may result in false
negatives. False negatives may also result from wells with high
transduction rates in which a certain proportion of cells identified
as GFP negative, will be expressing the ORF due to the generally
lower expression of proteins following an IRES [52,53,54], and
delays in production of sufficient GFP for detectable levels of
fluorescence.
Figure 5. Effect of transgene overexpression on 2-day growth
rate of FACS-purified cell populations. MCF-10A cells were
transduced with control (truncated CPNE3), CCNE1, CAPN3 or NEK6
vectors and sorted by flow cytometry for GFP expression (minimum
98% GFP positive cells). A- Cells were seeded in complete medium
(5%HS and EGF), and the next day media were replaced with either
reduced (1% HS no EGF) or complete medium. Cells were counted 1
and 3 days later and ratios calculated. Bars represent mean of 4 wells
and error bars show the standard deviation. B – Western blots of whole
cell protein extracts obtained from sorted cell lines after one freeze-
thaw cycle and 8 subsequent passages. Targeted antigen is indicated
on the left of the image while the introduced ORF is indicated on top of
each lane. Except for the no virus control, cells used were confirmed to
be .98% GFP positive prior to harvesting.
doi:10.1371/journal.pone.0020057.g005
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Of the 47 hits that increased the EdU incorporation rate 2 days
after transduction and EGF withdrawal, 11 also caused a
detectable increase in cell proliferation rate irrespective of the
promoter used to drive transgene expression. It is possible that the
genes that affected nucleotide incorporation but not cell
proliferation rate act on pathways that are specific to nucleotide
metabolism and/or DNA repair (eg. TK1, APEX1). Alternatively,
the effect of particular transgenes on cell proliferation may have
been temporary and/or too small to affect the cell numbers over
the course of the screen, but sufficient to cause a detectable
increase in EdU incorporation rate during the 2 hours of the
assay. CAPN3 and NEK6 overexpression also caused increased
proliferation rate in stably overexpressing cell lines isolated by
FACS. However, this increase was sustained for only a few
passages after sorting despite continued transgene overexpression,
suggesting that MCF-10A cells are capable of restoring prolifer-
ation control.
Our pilot screen was performed after EGF removal and under
reduced serum concentration in order to target genes that can
overcome G1 arrest. Because we chose assay conditions that
allowed 2–3 rounds of cell division to occur before the G1 phase
arrest, it is not altogether surprising that we identified as hits both
genes that have known G1/S phase promoting activity such as
RIT1 [46], CRK [55], and CDK2 [56], as well as genes that have
documented roles in G2/M phase progression such as CDC20
[49], NEK6 [45,57,58], BUB3 [51], ZWINT [50], and UBE2S
Figure 6. Cell cycle analysis of proliferation-inducing hits. A- DAPI intensity (x-axis) histograms (y-axis = number of objects) obtained by
CellCycle v3 application in the Cellomics ArrayScan Software, representing typical profiles observed on Day 0, Day 2 and Day 4 of the assay (Figure 2),
depending on growth conditions and viral transduction. Profiles and data shown are derived from a representative single well from each of the
categories: not transduced (no virus), transduced with empty plv101 vector, or with the vector expressing NEK6, analysed using cells grown in
complete or restrictive medium as indicated. The proportion of cells in each cell cycle phase is indicated (based on DNA content: 2N (%G1), between
2N and 4N (%S), and 4N (%G2)). B, C – Graphs representing the proportion of cells in G2 on day 2 (B) and day 4 (C) for proliferation-inducing hits
(Bars = mean of 3 wells; error bars = standard deviation). CMV, EF1a - values for clones expressed under control of the CMV and EF1a promoters
respectively. N.T-not transduced, control – truncated CPNE3. Values for all analysed genes are in Table S4, for all transduced wells, values represent
GFP positive cell population only.
doi:10.1371/journal.pone.0020057.g006
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[47,48,49]. Cell cycle analysis indicated that this is in part due to
the fact that the hit transgenes may be overcoming G2 phase block
caused by exposure to viral supernatant, instead of, or in addition
to the G1 phase block caused by growth factor withdrawal.
Although our analysis suggests that this is true for at least CADM1,
CDC20, CDK2, CELA2B, CLK2, KRT19, and NEK6, further
experiments are required to confirm the mechanism of transgene
action. Future whole genome screens could be designed with more
stringent conditions to target a specific cell cycle phase or
molecular pathway.
In conclusion, we have described protocols for the construction
and screening of a lentiviral ORF overexpression library, which
we have successfully tested in a screen for pro-proliferative genes.
The identification of hits that include genes previously known to
have this activity, as well as novel genes, demonstrates the utility
and relevance of our lentiviral overexpression screening platform
and provides directions for future more detailed functional analysis
of identified genes. This gain-of-function screening platform
complements the siRNA and shRNA depletion screens currently
available, and provides a powerful new approach for high-
throughput functional genomics.
Materials and Methods
Unless otherwise noted, all reagents were obtained from Sigma-
Aldrich (Sydney, Australia).
Plasmids, bacterial strains and cells
Bacterial cultures of entry clones in pDONOR223 or
pENTR201 vectors were picked respectively from the Human
ORFeome collection version 1.1 and 5.1 or from the Human
Orfeome collaboration OCAA collection (Open Biosystems), and
arrayed as indicated in Table S1. Gateway-cloning-compatible
lentiviral expression plasmids plv101G and plv411G, and the
lentiviral packaging plasmids [59] pRSV-Rev, pCMVdelta8.2 and
pVSV-G were obtained from S. Barry [60].
Entry clones were maintained in E.coli strain as supplied, in LB/
TB (1:1) medium supplemented with spectinomycin (50 mgml21).
Expression clones were transformed into a-Select Gold chemically
competent cells (Bioline), and maintained in 100 mgml21 ampicil-
lin in LB/TB. Cells were cultured in 96-deep-well Costar 3960
plates(Corning) in HigroTM multiplate incubator-shaker (Digilab),
and stored in 96-well Costar 3896 plates (Corning) in media
containing 10% glycerol at 270 C.
HEK293T (Broad Institute, Cambridge MA) cells were
maintained under standard tissue culture conditions in DMEM
supplemented with 10% (v/v) heat-inactivated fetal calf serum
(Hyclone), 0.85 mM HEPES, 2 mM L-glutamate, 1 mM sodium
pyruvate, 16 non essential amino acids (GIBCO).
MCF-10A cells (ATCC) were maintained in DMEM/F12 (1:1;
Invitrogen) supplemented with 5% (v/v) heat-inactivated horse
serum (Invitrogen), 10 mg/ml insulin, 20 ng/ml EGF, 0.5 mg/ml
hydrocortisone (Bayer), 100 ng/ml Cholera toxin, and penicillin/
streptomycin antibiotic (Invitrogen).
Robotic platform and plate handling
Multistep micro-plate protocols were performed with SciClone
ALH3000 liquid handling workstations (Caliper Life Sciences;
Hopkinton, MA, USA). Separate workstations were set up for
DNA and mammalian tissue culture experiments. Plate-washing
steps were performed with an ELx405 plate washer (BioTek
Instruments, Winooski VT, USA). Single 96-well liquid dispensing
steps, including cell seeding were performed with a Matrix
Wellmate (Thermo Scientific).
Expression clone generation
Entry clone plasmid DNA was isolated using Perfectprep plasmid
96 VAC kit (5 Prime) according to manufacturer’s instructions,
either manually using vacuum manifold (Eppendorf) or on the
SciClone ALH3000 robotic platform. Entry clones were transferred
into the expression vector using Gateway LR clonase II enzyme mix
(Invitrogen). The LR reactions were performed overnight at room
temperature in 96-well plates in a volume of 5 ml per well,
containing 1–100 ng of entry clone DNA, 100 ng expression
plasmid DNA and 0.6 ml enzyme mix in 3 mM Tris-HCL pH 8.
Reactions were stopped by addition of 3 ml of Protease K
(Invitrogen) diluted in water 1:1 (v/v). After 20 min at 37 C,
protease was heat inactivated at 90 C for 5 min. 2 ml of this was
transformed into 200 ml of a-Select Gold chemically competent cells
(Bioline) using a 45 s heat shock at 42 C. DNA was extracted from
the expression clones cultured in 2 ml LB/TB, as described above.
DNA concentrations in stock plates were determined using a
Powerwave microplate spectrophotometer (BioTek) and normalised
to 20 ng ml21 during a robotic transfer into a fresh set of plates that
served as source plates for transfection.
Virus production in HEK293T cells
Expression clone DNA (300 ng) was mixed with packaging
plasmids pRSV-Rev (150 ng), pCMV delta R8.2 (180 ng) and
pVSV-G (120 ng) in 19 ml per well in Costar 3896 plates.
LipofectamineTM 2000 transfection reagent (Invitrogen) was
incubated with OPTIMEM (Gibco) (1: 31, v/v) for 20–40 min at
RT, prior to adding to the DNA mix at 31 ml per well. HEK293T
cells were plated in 96-well SpectraPlates TC (Perkin Elmer) coated
with 0.1% gelatin, at 60000 cells in 200 ml per well. Cells were
allowed to settle for at least 2 h, before 50 ml of the DNA-
LipofectamineTM mix was added per well. The next day, 150 ml of
medium was aspirated from each well and replaced with medium
containing 1 mM Sodium Butyrate. After 48 h, virus (180 ml from
each well) was harvested into Costar 3896 plates and stored at
270 C until use. Cells remaining in transfection plates were washed
in PBS, and fixed with 10% formalin. To confirm virus production,
plates were scanned for total well GFP fluorescence using Fluostar
OPTIMA (BMG Labtech) micro-plate reader.
Transduction and screening of MCF-10A cells
MCF-10A cells were seeded in complete media in black, clear-
bottom 96-well Viewplates (PerkinElmer), at 2000 cells in 130 ml
per well. The next day medium was aspirated such that 20 ml per
well remained. Viral plates were prepared by combining 20 ml of
viral supernatant with 9 ml of Polybrene (40 mgml21 in complete
medium) in each well; this mixture was then added to each well of
MCF-10A cells. Plates were incubated for 2–4 h before 150 ml of
low serum media (lacking EGF and containing only 1% serum)
was added to each well. The next day 150 ml of media was
aspirated from each well and replaced with fresh low serum media.
After a 48 hr incubation, cells were pulse labeled with 10 mM EdU
(Berry and Associates; Dexter, MI, USA) for 2 h and fixed in 3.7%
formaldehyde in PBS. EdU was subsequently cross-linked to Cy5-
azide and nuclei were stained with 400 nM DAPI as detailed by
Ranall et al [21]. Images were acquired with a Cellomics
ArrayScan VTI (Thermo Scientific) high-content imager, using a
106 objective and an XF93 filter set.
Protein blots
Harvested cells were collected by centrifugation, resuspended in
SDS-loading buffer, separated by polyacrylamide gel electropho-
resis on a 10% gel, and transferred to Hybond-P membrane
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(Amersham) by semi-dry transfer using BIO-RAD Mini-Protean
and Trans-Blot systems according to manufacturers recommen-
dations. Blots were probed with primary gene specific antibodies:
mouse monoclonal anti-CCNE1(HE12) (Santa Cruz)1:500, mouse
monoclonal anti alpha tubulin 1: 500 (Sigma), or rabbit
monoclonal anti-NEK6 (Epitomics)1:10000; then secondary horse
radish peroxidise-conjugated anti mouse (1:2000) or anti rabbit
(1:2000) sera (Invitrogen). Signal was detected using Western
Lighting-ECL reagent (Perkin-Elmer).
High-content image analysis
Images were analysed using the TargetActivation.v3 application
in the Cellomics ArrayScan software. Objects were selected and
nuclear area and shape measured in the DAPI channel. Total and
average pixel intensity was measured in DAPI, GFP and Cy5
channels and population statistics collected for objects in each well.
Data was then exported using the Cellomics Explorer software and
further analysed using the R software environment which allowed
data manipulation without image rescan.
The first step in the analysis was to determine the GFP and EdU
status of each cell. Analysis of EdU and GFP fluorescence intensity
revealed that setting simple thresholds introduced false positive
and false negative calls caused by variable background staining
and cell crowding. These artefacts were eliminated by setting
regression-based thresholds as follows:
EdU status: To determine EdU status, we used scatter-plots of
total nuclear DAPI vs total nuclear Cy5 fluorescence intensity. As
shown in Figure S3A, the variable background staining produced
during Cy5-labelling of EdU, resulted in a rising baseline making
setting single threshold invalid. To compensate, we performed
robust regression using the lmrob function within the ‘‘robust
regression’’ library of R (http://cran.r-project.org/). This method
fits a linear approximation to the background of Cy5-EdU
negative nuclei and identifies outliers, the Cy5-EdU positive cells.
In cases where more than 50% of cells are EdU positive, the
background of EdU negative cells is fit iteratively using successive
rounds of robust regression and excluding the outliers until the
regression curve converges with the non proliferating back-
ground.
GFP status: In densely populated fields with a high proportion
of GFP positive cells, we observed nuclei of non-transduced cells
whose edges overlapped with the cytoplasm of GFP positive cells,
resulting in above threshold fluorescence in some nuclei of cells not
expressing GFP. The false positive GFP cells were identified in
plots of log2(variance GFP intensity ) vs log2(mean GFP intensity)
as a distinct cloud of above-threshold GFP signal but with high
fluorescence variance (See Figure S3B). These false GFP-positive
cells were excluded using a quadratic fit of GFP cells above the
background threshold (based on average nuclear GFP pixel
intensity) again using the lmrob function in R. EdU and GFP
regression analysis plots were automatically generated for all wells
in the screen, and visually inspected for putative hit wells to verify
that the methods performed as expected. Failures were observed at
a frequency of less than 0.5%, and usually generated false positives
in wells with small numbers of cells; these were eliminated from
the hit list.
Identification of hits
EdU incorporation rates in the transduced population were
calculated using a z-score based on a binomial distribution. In this
case the z-score tests whether the proportion of EdU positive cells
is different in the transduced (GFP positive) population to that in
the untransduced (GFP negative) population for each well:
z~
NEG{NGPEG-ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
NGPEG- 1{PEG-ð Þ
p
where PEG - is the proportion of the EdU positive among the GFP
negative cells, NEG is the number of EdU positive GFP positive
cells and NG is the number of GFP positive cells. The standard
deviation for a binomial distribution in the denominator negatively
weights apparent hits based on only a small number of green cells.
Wells where NEG,50 were rejected from analysis. The advantage
of this approach is that the negative control/untransuced cells are
in the same well and are exposed to the same micro-environment
as the test/transduced cells, so that the score compensates for the
variation due to plate-edge effects and inaccuracies in pipetting
volume, as well as different transduction rates in the test wells. This
method assumes that GFP positive cells express the test protein
while the GFP negative cells do not, and requires that both
transduced and untransduced cells be present in the well. It can be
assumed that GFP positive cells expressed the ORF, because the
ORF is located upstream of the IRES-GFP cassette on the same
transcript, and it has been extensively documented that proteins 59
to an IRES are expressed at levels equal to or higher than the
proteins downstream of this sequence [52,53,54]. Moreover, we
have confirmed that GFP expression correlates with expression of
the test ORF as detected by immunofluorescence for at least 4
genes (see Figure S4).
As there was considerable variability between plates, z-scores
were normalized by plate median centering. Positive control wells
and wells containing fewer than 50 GFP positive cells were
excluded from median calculations. After the inter-plate variation
has been removed, and positive controls excluded, the normalised
z-scores were normally distributed (Shapiro test with a p-
value.0.05). These normalized z-scores were then used for hit
selection by employing Q-Q plots (see text and Figure 3).
Cell cycle analysis of hit plates was performed by rescanning
images with the ArrayScan CellCycle.v3 application. Intensity
peak thresholds in the DAPI channel were set individually for each
plate using untransduced wells to model intensity curves.
Supporting Information
Figure S1 Comparison of Plate reader, high-content
imaging and flow cytometer analysis of GFP fluores-
cence following transfection. 96-well microplates were
seeded with HEK293T cells and transfected with lentiviral
plasmids as described in methods. A, cells were fixed and stained
with DAPI, and the plate scanned on either the FLUOstar
Optima Microplate Fluorometer (plate reader) or with Cellomics
ArrayScan HCS reader. B, live cells were washed with PBS and
scanned on the plate reader. Cells in each well were then
trypsinised, collected into 5 ml tubes and fixed. The tubes were
individually scanned on a BD FACS Canto Flow Cytometer
(FACS).
(TIF)
Figure S2 Transfection and transduction rate variation
between genes and within replicates of the same gene. A
- Transfection rate for vectors expressing the indicated genes was
estimated by GFP fluorescence of transfected HEK293T as
measured by plate reader. B - Transduction rate was obtained
using the HCS reader by scanning the MCF-10A cells exposed to
the viral supernatant derived from the HEK293T cells in A.
Shaded bars within a group represent replicate wells.
(TIF)
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Figure S3 Regression plots for identifying EdU and GFP
positive cells. A - Scatter-plot of total nuclear DAPI vs total
nuclear Cy5 fluorescence intensity. A regression method (see
Materials and Methods) fits a linear approximation to the
background of Cy5-EdU negative nuclei and identifies outliers,
the Cy5-EdU positive cells (shown in red). B - Plots of
log2(variance GFP intensity ) vs log2(mean GFP intensity) identify
false GFP-positive cells as a distinct cloud with above-threshold
GFP signal but with high fluorescence variance. Identified GFP
positive cells are shown in green.
(TIF)
Figure S4 Comparison of library ORF and GFP expres-
sion. Transduced MCF-10A cells were processed as in the screen
assay, except that after fixation they were immunolabelled with
primary antibody against the ORF (monoclonal mouse anti-
cytokeratin 19 (Invitrogen) or rabbit polyclonal anti-CDK2 (B. G.,
unpublished), and then secondary antibody conjugated to TRITC
(anti-mouse-TRITC or anti-rabbit-TRITC, respectively (Santa-
Cruz)). A- Immunofluorescence micrographs of cells overexpress-
ing CMV-driven KRT19 (KRT19-GFP) or CDK2 (CDK2-GFP),
followed by the IRES-driven GFP, or empty vector expressing
GFP alone. Colocalisation of the GFP and TRITC signal was
observed only if the cells were treated with the antibody
corresponding to the overexpressed ORF. B – scatter plots of
GFP vs TRITC signal intensity obtained by high-content image
analysis of the immunolabelled cells, indicating presence of the
above background TRITC signal only in cells overexpressing the
ORF corresponding to the targeted antigen. Similar data were
obtained for cells transduced with CCNE1 and PCNA overex-
pression clones (not shown).
(TIF)
Table S1 Primary screen analysis.
(XLSX)
Table S2 Confirmation screen analysis.
(XLSX)
Table S3 Hit proliferation rate analysis.
(XLSX)
Table S4 Hit cell cycle analysis.
(XLSX)
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